tradingkey.logo

Autonomix Medical Reports Positive Outcomes In Initial Phase Of First-In-Human Proof-Of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study For Visceral Cancer Pain

ReutersApr 30, 2025 12:17 PM

- Autonomix Medical Inc AMIX.O:

  • AUTONOMIX MEDICAL, INC. REPORTS POSITIVE OUTCOMES IN INITIAL PHASE OF FIRST-IN-HUMAN PROOF-OF-CONCEPT TRIAL IN PANCREATIC CANCER PAIN AND INITIATES MARKET EXPANSION STUDY FOR VISCERAL CANCER PAIN

  • AUTONOMIX MEDICAL INC - NO DEVICE OR PROCEDURE-RELATED SERIOUS ADVERSE EVENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI